PI-RADS: where next?

B Turkbey, AS Purysko - Radiology, 2023 - pubs.rsna.org
Prostate MRI plays an important role in the clinical management of localized prostate
cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate …

Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy

JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

[HTML][HTML] Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer

FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2023 - Mass Medical Soc
Background Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and
69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer …

[HTML][HTML] Prostate cancer screening with PSA and MRI followed by targeted biopsy only

J Hugosson, M Månsson, J Wallström… - … England Journal of …, 2022 - Mass Medical Soc
Background Screening for prostate cancer is burdened by a high rate of overdiagnosis. The
most appropriate algorithm for population-based screening is unknown. Methods We invited …

Artificial intelligence and radiologists at prostate cancer detection in mri—the pi-cai challenge

A Saha, J Bosma, J Twilt, B van Ginneken… - Medical Imaging with …, 2023 - openreview.net
We hypothesized that state-of-the-art AI models, trained using thousands of patient cases,
are non-inferior to radiologists at clinically significant prostate cancer diagnosis using MRI …

[HTML][HTML] Guidelines for genetic testing in prostate cancer: a scoping review

H Tuffaha, K Edmunds, D Fairbairn… - Prostate Cancer and …, 2023 - nature.com
Background Genetic testing, to identify pathogenic or likely pathogenic variants in prostate
cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform …

[HTML][HTML] Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data

G Gandaglia, F Pellegrino, A Golozar, B De Meulder… - European Urology, 2024 - Elsevier
Background Conservative management is an option for prostate cancer (PCa) patients
either with the objective of delaying or even avoiding curative therapy, or to wait until …

Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI‐algorithm for lesion detection …

B Oerther, H Engel, A Nedelcu, CL Schlett… - The …, 2023 - Wiley Online Library
Abstract Background Multiparametric MRI (mpMRI) improves the detection of aggressive
prostate cancer (PCa) subtypes. As cases of active surveillance (AS) increase and tumor …

MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer

M Alabousi, S Ghai, MA Haider - Radiology, 2023 - pubs.rsna.org
Two cases involving patients diagnosed with localized prostate cancer and treated with MRI-
guided focal therapies are presented. Patient selection procedures, techniques, outcomes …

A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients

W Ebrahimizadeh, KP Guérard, S Rouzbeh… - British Journal of …, 2023 - nature.com
Background Distinguishing between true indolent and potentially life-threatening prostate
cancer is challenging in tumours displaying clinicopathologic features associated with low or …